| PD-Paed Plus Ģý PD in the smallest patients | |
|---|---|
| Easy-to-use preassembled system | PD-Paed Plus is designed to perform PD manually in premature babies, neonates and infants. It is an easy-to-use preassembled system for in-center use. |
| Flexible treatment adaptation |
|
| Safety features give confidence |
|
*Calculated on basis of a 2 exchanges per day prescription
| Treatments tailored to young patients |
|---|
| sleepĢýsafe harmonyis a device to treat children on automated PD, in general during the night time at home. It offers high flexibility to tailor a treatment according to the individual needs of the patient: |
| Adjustable flow rates for low volume treatments |
| Special pediatric disposable set for low volumes |
| Option to perform ĢýAdapted APD (aAPD)Ģý by varying dwell time and fill volume. |
| Giving parents the option in the treatment and its comfort |
| Integrated on-device animations guiding through the treatment procedure |
| Quiet hydraulic pump system enables a good nightĢýs sleep |
| PIN technology reduces the number of risk steps associated with disconnection and reconnection* |
* Calculated on basis of a 4 bag connections per day prescription
Experts recommend that biocompatible multi-chambered PD fluids which are low in glucose degradation products (GDP) should become the standard of care for children on PD2. Children dialyzed with biocom¬patible PD fluid show significant catch-up growth when compared to children on conventional solutions3.
The concentration of glucose degradation products (GDPs) differs considerably. balance and bicaVerashow lowest levels of GDPs compared to other biocompatible PD fluids7.
bicaVerais purely bicarbonate-buffered and proven to better correct metabolic acidosis than lactate containing PD fluids4,5. It is recommended in end stage renal failure2.
The use of bicarbonate-buffered PD fluids in comparison to conventional lactate-buffered fluids is associated with lower incidence of infusion pain4and reduced capillary recruitment2.
Biocompatible fluids are essential for growth
Biocompatible PD fluids are not all the same
Abbreviated Prescribing Information PD fluids
PDF, 29 KB
Abbreviated Prescribing balance
PDF, 17 KB
Abbreviated Prescribing bicaVera
PDF, 17 KB1KDOQI Clinical Practice recommendations for PD adequacy. Am J Kidney Dis. 2006; 48 Suppl 1:146-158
2Schmitt CP, Bakkaloglu SA, Klaus G, Schroeder C, Fischbach M: Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group. Pediatric Nephrology 2011; 26(7):1137Ģý47, page 1140.
3Rees L, Azocar M, Borzych D, Watson AR, Büscher A, Edefonti A, Bilge I, Askenazi D, Leozappa G, Gonzales C, van Hoeck K, Secker D, Zurowska A, Rönnholm K, Bouts AHM, Stewart H, Ariceta G, Ranchin B, Warady BA, and Schaefer F, for the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Growth in very young children undergoing chronic peritoneal dialysis. Journal of the American Society of Nephrology 2011; 22: 2303Ģý2312, page 2307
4Feriani M, Kirchgessner J, La Greca G, Passlick-Deetjen J. Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney International 1998;54(5):1731, 1732.
5Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F: Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. Journal of the American Society of Nephrology 2003;14:2632-38.
6Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2002;13(2):480-9. Erratum in: Journal of the American Society of Nephrology 2002;13(5):1419-22, page 486.
7Himmele R, Jensen L, Fenn D, Ho C, Sawin D, DiazĢýBuxo J. A new neutral-pH low-GDP peritoneal dialysis fluid. Peritoneal Dialysis International 2012;32(4):449.
8Wieskotten S, Knobloch V, Wiemann K, Wabel P, Wühl E, Schäfer F. Use of the BCMĢýbody composition monitor in children Ģý establishing new reference ranges. Pediatric Nephrology 2008; 23:1571Ģý719.
9Dasgupta I, Keane D, Lindley E, Shaheen I, Tyerman K, Schaefer F, Wühl E, Müller M, Bosy-Westphal A, Fors H, Dahlgren J, Chamney P, Wabel, P, Moissl U. Validating the use of bioimpedance spectroscopy for assessment of fluid status in children. Pediatric Nephrology (2018) 33:1601Ģý1607.
10Eng C, Bhowruth D, Mayes M, Stronach, L, Blaauw M, Barber A, Rees L, Shroff R. Assessing the hydration status of children with chronic kidney disease and on dialysis: a comparison of techniques. Nephrol Dial Transplant (2018) 33: 847Ģý855.